Huemer and colleagues have developed a diagnostic and management pathway for patients with a suspected remethylation disorder and have provided a comparison of the various cobalamin defects associated with hyperhomocysteinemia, the respective enzymatic/incorporations tests available, and the genes involved in these diseases (see Table 4) (101)
Anyone considering IV therapy should undergo screening for conditions like glucose 6 phosphate dehydrogenase (G6PD) deficiency, kidney problems, and iron overload
paracetamol, sometimes called acetaminophen), and sometimes even when introduced within therapeutic ranges (e.g
they are not FDA-approved for general consumer use, retail sale or recreational selfadministration and are dispensed exclusively through licensed pharmacies to patients under active clinical care
Scientists are now exploring combinations of copper peptides with stem-cell extracts, nanotechnology delivery systems, and bio-identical growth factors to maximise absorption and results